347 related articles for article (PubMed ID: 27429590)
1. Expression of SRSF3 is Correlated with Carcinogenesis and Progression of Oral Squamous Cell Carcinoma.
Peiqi L; Zhaozhong G; Yaotian Y; Jun J; Jihua G; Rong J
Int J Med Sci; 2016; 13(7):533-9. PubMed ID: 27429590
[TBL] [Abstract][Full Text] [Related]
2. HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells.
Jia R; Zhang S; Liu M; Zhang Y; Liu Y; Fan M; Guo J
Sci Rep; 2016 Nov; 6():35976. PubMed ID: 27808105
[TBL] [Abstract][Full Text] [Related]
3. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
4. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
Sun Y; Yan L; Guo J; Shao J; Jia R
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of cancer stem-like and epithelial-mesenchymal transdifferentiation property in oral epithelial cells with long-term nicotine exposure: reversal by targeting SNAIL.
Yu CC; Chang YC
Toxicol Appl Pharmacol; 2013 Feb; 266(3):459-69. PubMed ID: 23219715
[TBL] [Abstract][Full Text] [Related]
8. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.
Zhang L; Pan HY; Zhong LP; Wei KJ; Yang X; Li J; Shen GF; Zhang Z
J Oral Pathol Med; 2010 Jul; 39(6):470-6. PubMed ID: 20149058
[TBL] [Abstract][Full Text] [Related]
9. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
[TBL] [Abstract][Full Text] [Related]
10. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
Xu L; Shen J; Jia J; Jia R
Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
[TBL] [Abstract][Full Text] [Related]
11. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.
Guo J; Jia J; Jia R
Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal regulation of miR-1254 and c-Myc in oral squamous cell carcinoma suppresses EMT-mediated metastasis and tumor-initiating properties through MAPK signaling.
Lu M; Chen WH; Wang CY; Mao CQ; Wang J
Biochem Biophys Res Commun; 2017 Mar; 484(4):801-807. PubMed ID: 28161631
[TBL] [Abstract][Full Text] [Related]
13. [Expression and potential clinical significance of cytidine triphosphate: phosphocholine cytidylyltransferase-α in oral squamous cell carcinoma].
Lu FC; Xie XY; Yin XM; Gao YJ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):254-258. PubMed ID: 29690696
[No Abstract] [Full Text] [Related]
14. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma.
Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X
Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
[TBL] [Abstract][Full Text] [Related]
16. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of insulin-like growth factor binding protein 3 in oral squamous cell carcinoma.
Zhong LP; Yang X; Zhang L; Wei KJ; Pan HY; Zhou XJ; Li J; Chen WT; Zhang ZY
Oncol Rep; 2008 Dec; 20(6):1441-7. PubMed ID: 19020726
[TBL] [Abstract][Full Text] [Related]
18. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
[TBL] [Abstract][Full Text] [Related]
19. Peroxiredoxin 1 promotes invasion and migration by regulating epithelial-to-mesenchymal transition during oral carcinogenesis.
Niu W; Zhang M; Chen H; Wang C; Shi N; Jing X; Ge L; Chen T; Tang X
Oncotarget; 2016 Jul; 7(30):47042-47051. PubMed ID: 27259998
[TBL] [Abstract][Full Text] [Related]
20. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.
Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC
J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
